Enforcement In Brief
This article was originally published in The Tan Sheet
Executive Summary
Exec charged in bird flu claim case
You may also be interested in...
NDI Notification Draft Guidance Seminar In Brief
History of use, toxicology studies key
H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA
FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.
“Fowl” Play? FDA Warning Letters Target Avian Flu Supplement Marketers
Nine dietary supplement firms who received FDA warning letters for marketing their products as treatments for avian flu could face "far more serious enforcement activity" if they do not take "immediate corrective action," according to an industry lawyer